Your browser doesn't support javascript.
loading
Prognostic role of circulating exosomal miRNAs in multiple myeloma.
Manier, Salomon; Liu, Chia-Jen; Avet-Loiseau, Hervé; Park, Jihye; Shi, Jiantao; Campigotto, Federico; Salem, Karma Z; Huynh, Daisy; Glavey, Siobhan V; Rivotto, Bradley; Sacco, Antonio; Roccaro, Aldo M; Bouyssou, Juliette; Minvielle, Stéphane; Moreau, Philippe; Facon, Thierry; Leleu, Xavier; Weller, Edie; Trippa, Lorenzo; Ghobrial, Irene M.
Afiliación
  • Manier S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Liu CJ; Department of Hematology, University Hospital Center of Lille, Lille, France.
  • Avet-Loiseau H; INSERM Unité Mixte de Recherche (UMR)-S1172, Lille 2 University, Lille, France.
  • Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Shi J; Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Campigotto F; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Salem KZ; Laboratory for Genomics in Myeloma, INSERM Unité 1037, Toulouse University Hospital, Toulouse, France.
  • Huynh D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Glavey SV; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Rivotto B; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Sacco A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Roccaro AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Bouyssou J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Minvielle S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Moreau P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Facon T; Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Coordinamento e Progettazione Ricerca Clinica, Compressible-Fluid Dynamics for Renewable Energy Applications (CREA) Laboratory, Brescia, Italy.
  • Leleu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Weller E; Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Coordinamento e Progettazione Ricerca Clinica, Compressible-Fluid Dynamics for Renewable Energy Applications (CREA) Laboratory, Brescia, Italy.
  • Trippa L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ghobrial IM; Center for Cancer Research Nantes-Angers, UMR-892 INSERM-6299 Centre National de la Recherche Scientifique, and.
Blood ; 129(17): 2429-2436, 2017 04 27.
Article en En | MEDLINE | ID: mdl-28213378

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / MicroARNs / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Marruecos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / MicroARNs / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Marruecos